Kristen Sanfilippo

Medicine & Life Sciences

1. Venous Thromboembolism 100%
2. Multiple Myeloma 68%
3. Veterans 52%
4. Thrombosis 30%
5. Hematology 30%
6. Lymphoma, Large B-Cell, Diffuse 27%
7. Anticoagulants 27%
8. Hemorrhage 22%
9. Guidelines 21%
10. Survival 19%
11. Mortality 17%
12. Critical Illness 14%
13. Coronavirus 14%
14. Confidence Intervals 14%
15. Hemostasis 13%
16. Hematologic Neoplasms 12%
17. Cohort Studies 12%
18. Neoplasms 12%
19. Retrospective Studies 12%
20. Therapeutics 12%
21. Warfarin 12%
22. Drug Therapy 11%
23. Hodgkin Disease 11%
24. Hydroxymethylglutaryl-CoA Reductase Inhibitors 11%
25. Pancreatic Neoplasms 10%
26. Sarcopenia 10%
27. apixaban 9%
28. United States Department of Veterans Affairs 9%
29. Rivaroxaban 9%
30. abiraterone 8%
31. Patient Advocacy 8%
32. MDV 3100 8%
33. Veterans Health 8%
34. International Classification of Diseases 8%
35. Monoclonal Gammopathy of Undetermined Significance 8%
36. Pamidronate 7%
37. Obesity 7%
38. Population 7%
39. Second Primary Neoplasms 7%
40. Incidence 7%
41. Zoledronic Acid 7%
42. Conflict of Interest 7%
43. Fibrinolytic Agents 6%
44. International Normalized Ratio 6%
45. Immunomodulation 6%
46. Frailty 6%
47. Anthracyclines 6%
48. Bleomycin 6%
49. Registries 6%
50. Kidney Neoplasms 6%